论文部分内容阅读
目的:研究血小板活化指标及血小板参数在乙肝肝硬化患者中的检测价值。方法:选取2015年11月~2016年8月期间于本院进行诊治的40例乙肝肝硬化患者为观察组,同时期的40名体检结果为健康的人员为对照组,检测与比较两组同龄人员的血小板活化指标及血小板参数,并比较不同分期乙肝肝硬化患者的上述两方面检测结果。结果:观察组的PLT低于对照组,其他血小板参数及血小板活化指标均高于对照组,且不同分期乙肝肝硬化患者的上述两方面检测结果也存在明显差异,P均<0.05,比较结果间均有显著性差异。结论:乙肝肝硬化患者的血小板活化指标及血小板参数表达明显异常,且不同肝硬化分期患者的表达水平也存在显著性差异,因此应加强对乙肝肝硬化患者上述指标的监测。
Objective: To investigate the value of platelet activation and platelet parameters in the diagnosis of hepatitis B cirrhosis. Methods: Forty patients with hepatitis B cirrhosis who were diagnosed and treated in our hospital from November 2015 to August 2016 were selected as the observation group, and 40 healthy people were selected as the control group in the same period. The patients of the same age Personnel platelet activation indicators and platelet parameters, and compare the different stages of hepatitis B cirrhosis in patients with the above two test results. Results: The PLT in the observation group was lower than that in the control group, and the other platelet parameters and platelet activation index were higher than those in the control group. There was also significant difference between the two groups in the detection of hepatitis B cirrhosis (P <0.05) There are significant differences. Conclusion: The platelet activation index and platelet parameter of patients with hepatitis B cirrhosis are obviously abnormal. There are also significant differences in the expression level of patients with different stages of liver cirrhosis. Therefore, we should strengthen the monitoring of these indexes in patients with hepatitis B cirrhosis.